The Optimal Time to Put Laryngeal Mask Airway in the Mouth Under General Anesthesia
LMA
The Optimal Time of Insertion of Laryngeal Mask Airway With Propofol Induction
1 other identifier
interventional
198
1 country
1
Brief Summary
Laryngeal mask airway (LMA) is routinely used for some patients who have surgery under general anesthesia. LMA is placed in the mouth and allow the anesthesia to be given without having to put a breathing tube in the throat. Previous studies have focused on the effect of different anesthesia medicines on optimal condition for LMA use. The objective of the present study is to find the optimal time for LMA insertion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 3, 2009
CompletedFirst Posted
Study publicly available on registry
September 7, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 4, 2013
December 1, 2013
4.3 years
September 3, 2009
December 3, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Ease of Mouth opening
From Induction of general anesthesia to satisfactory LMA insertion
Study Arms (1)
0 sec, 60 sec, 90 sec
OTHERLMA will be inserted at 0, 60, and 90 seconds after eyelash reflex disappears
Interventions
The LMA will be inserted at 0 sec, 60 sec. and 90 sec. after induction of general anesthesia
Eligibility Criteria
You may qualify if:
- subjects 18 years or older
- ASA status 1-3
You may not qualify if:
- high risk of aspiration
- anticipated difficult airway
- use of sedative drugs
- patient refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tufts Medical Center
Boston, Massachusetts, 02111, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pei-shan Zhao, MD,PhD
Tufts Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2009
First Posted
September 7, 2009
Study Start
September 1, 2009
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
December 4, 2013
Record last verified: 2013-12